Exciting talks from pioneers in genetic therapy, interdisciplinary networking, and tasty food.
Is there anything to win?
Yes! Submit your abstract till Nov. 8 and win 600€ (1. price), 400€ (2. price) or 200€ (3. price) as well as
a follow-up talk in the AGD meeting next year.
How?
Send an email (best with your abstract) to info@agdev.de or use the web registration form below.
Our new Media Partner is the Rare Disease and Orphan Drugs Journal. All submissions from the conference will be totally free for publication and will enjoy free language polishing sevice after acceptance by the journal.
Preliminary program (see flyer link below for an updated version)
Thursday, December 09
12:00–12:45 Lunch Break and Opening of the Industrial Exhibition
12:45–13:00 Welcome and Opening of Symposium
Ingo Kurth, Chair of the Program Committee
Peter Krawitz, President of AGD
13:00–15:30 German NGS competence centers
Session Chair: Joachim Schultze, DZNE, Germany
13:00–13:30 Nikolay Ninov (Center for Regenerative Therapies, Dresden)
Towards in vivo regeneration of beta-cells as a future therapy for T1D
13:30–14:00 Philipp Rosenstiel (Institute for Clincial Molecular Biology, Kiel)
System Immunology of Inflammatory Disorders – one cell at a time
14:00–14:30 Joachim Schultze (DZNE, Bonn)
Swarm Learning for decentralized and confidential clinical machine learning
14:30–15:00 Yogesh Singh (NGS Competence Center, Tübingen)
Single cell view of the immune response in COVID-19 vaccinated individuals
15:00-15:15 Jochen Seggewiss (Twist Biosciences)
One step ahead - Fast & flexible NGS solutions for FFPE- and cfDNA
15:15-15:30 Michael Papen (comma-soft)
Accelerate Research with FastGenomics
15:30–16:00 Coffee Break, Industrial Exhibition and Poster Viewing
16:00–18:00 New targeting approaches
Session Chair: Peter Krawitz, University Hospital Bonn
16:00–16:30 Hildegard Büning (German Center for Infection Research, Hannover)
Gene therapy from concept to proof
16:30–17:00 Dimitrios Wagner (Charité University Medicine Berlin)
Engineering designer immune cell therapies with CRISPR-Cas gene editing
17:00–17:30 Eva Rettinger (Univeristy Hospital Frankfurt)
CAR-T cell therapy in children with ALL: Current Status and Perspectives
17:30–17:45 Mario Avarello (TaKaRa)
Harnessing full-length scRNA-seq to empower biomarker discovery
17:45-18:00 Lia Burkhardt (10x Genomics)
Reaching new levels of biology with single cell and spatial multiomics
18:00–19:00 Buffet, Opening Networking Mixer (exhibitors are invited)
19:00–20:00 Keynote lecture by Paolo Martini, SCO of Moderna
mRNA as a platform for different therapeutic areas
20:00–21:00 Klaviersonaten, Ludwig van Beethoven (Soheil Nasseri)
21:00–22:00 Antiviral cocktails at the Bar
Friday, December 10
9:00–11:00 Identification of patients with treatable causes
Session Chair: Ingo Kurth, Human Genetics, RTWH Aachen, Germany
09:00–09:30 Peter Krawitz (University Hospital Bonn, Bonn, Germany)
GestaltMatcher: Next-generation phenotyping on medical imaging
09:30–10:00 Dieter Beule (BIH, Berlin, Germany)
VarFish - Collaborative Exome Analysis
10:00–10:30 Daniel Scherman (Foundation for Rare Disease FRRD, France)
New genetic and repositioning therapies for rare diseases
10:00-10:30 Heiko Krude (Charité University Medicine, Berlin, Germany)
Implementation of exome sequencing in the clinical workup of patients with unsolved rare diseases: Results and implications of the TRANSLATE NAMSE project
11:00–11:30 Coffee Break, Industrial Exhibition and Poster Viewing
11:30–13:30 New therapies for genetic disorders
Session Chair: Sebahattin Cirak, University Hospital Cologne, Germany
